相似文献
1
Relation of virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro.
J Exp Med. 1950 Jul 1;92(1):1-9. doi: 10.1084/jem.92.1.1.
2
Control by factors distinct from the S transforming principle of the amount of capsular polysaccharide produced by type III pneumococci.
J Exp Med. 1953 Jun;97(6):767-71. doi: 10.1084/jem.97.6.767.
3
Simultaneous production of two capsular polysaccharides by pneumococcus. II. The genetic and biochemical bases of binary capsulation.
J Exp Med. 1959 Oct 1;110(4):585-602. doi: 10.1084/jem.110.4.585.
4
STEPWISE INTRATYPE TRANSFORMATION OF PNEUMOCOCCUS FROM R TO S BY WAY OF A VARIANT INTERMEDIATE IN CAPSULAR POLYSACCHARIDE PRODUCTION.
J Exp Med. 1947 Nov 30;86(6):439-52. doi: 10.1084/jem.86.6.439.
5
Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae.
Infect Immun. 1999 May;67(5):2327-33. doi: 10.1128/IAI.67.5.2327-2333.1999.
6
Action of capsular polysaccharide and a polygalacturonate on the development and the virulence of Pneumococcus type III.
Experientia. 1952 May 15;8(5):190-2. doi: 10.1007/BF02173739.
7
Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells.
Infect Immun. 2005 Aug;73(8):4653-67. doi: 10.1128/IAI.73.8.4653-4667.2005.
8
Capsulation of pneumococcus with soluble cell wall-like polysaccharide. II. Nonidentity of cell wall and soluble cell wall-like polysaccharides derived from the same and from different pneumococcal strains.
J Exp Med. 1971 Sep 1;134(3 Pt 1):600-17. doi: 10.1084/jem.134.3.600.
9
Capsulation of pneumococcus with soluble C-like (Cs) polysaccharide. I. Biological and genetic properties of Cs pneumococcal strains.
J Exp Med. 1968 Dec 1;128(6):1385-400. doi: 10.1084/jem.128.6.1385.
10
The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus.
J Immunol. 1976 Feb;116(2):367-70.
引用本文的文献
1
Cellular Mn/Zn Ratio Influences Phosphoglucomutase Activity and Capsule Production in Streptococcus pneumoniae D39.
J Bacteriol. 2021 Jun 8;203(13):e0060220. doi: 10.1128/JB.00602-20.
2
and Evaluation of Predicted Pneumococcal UDPG:PP Inhibitors.
Front Microbiol. 2020 Jul 15;11:1596. doi: 10.3389/fmicb.2020.01596. eCollection 2020.
3
Elaborates Persistent and Prolonged Competent State during Pneumonia-Derived Sepsis.
Infect Immun. 2020 Mar 23;88(4). doi: 10.1128/IAI.00919-19.
4
Pneumococcal serotype determines growth and capsule size in human cerebrospinal fluid.
BMC Microbiol. 2020 Jan 20;20(1):16. doi: 10.1186/s12866-020-1700-7.
5
Age does not influence the disease course in a mouse model of serotype 3 meningitis.
Immun Ageing. 2018 Sep 7;15:20. doi: 10.1186/s12979-018-0129-4. eCollection 2018.
6
A Quorum-Sensing System That Regulates Biofilm Formation and Surface Polysaccharide Production.
mSphere. 2017 Sep 13;2(5). doi: 10.1128/mSphere.00324-17. eCollection 2017 Sep-Oct.
7
Position of O-Acetylation within the Capsular Repeat Unit Impacts the Biological Properties of Pneumococcal Serotypes 33A and 33F.
Infect Immun. 2017 Jun 20;85(7). doi: 10.1128/IAI.00132-17. Print 2017 Jul.
8
A Streptococcus pneumoniae infection model in larvae of the wax moth Galleria mellonella.
Eur J Clin Microbiol Infect Dis. 2012 Oct;31(10):2653-60. doi: 10.1007/s10096-012-1609-7. Epub 2012 Apr 1.
9
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis.
Clin Infect Dis. 2010 Sep 15;51(6):692-9. doi: 10.1086/655828.
10
New adhesin functions of surface-exposed pneumococcal proteins.
BMC Microbiol. 2010 Jul 12;10:190. doi: 10.1186/1471-2180-10-190.
本文引用的文献
1
STEPWISE INTRATYPE TRANSFORMATION OF PNEUMOCOCCUS FROM R TO S BY WAY OF A VARIANT INTERMEDIATE IN CAPSULAR POLYSACCHARIDE PRODUCTION.
J Exp Med. 1947 Nov 30;86(6):439-52. doi: 10.1084/jem.86.6.439.
2
THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND HOMOLOGOUS ANTIBODY : III. A QUANTITATIVE STUDY AND A THEORY OF THE REACTION MECHANISM.
J Exp Med. 1935 Mar 31;61(4):563-91. doi: 10.1084/jem.61.4.563.
3
THE PRECIPITIN REACTION BETWEEN TYPE III PNEUMOCOCCUS POLYSACCHARIDE AND HOMOLOGOUS ANTIBODY : II. CONDITIONS FOR QUANTITATIVE PRECIPITATION OF ANTIBODY IN HORSE SERA.
J Exp Med. 1935 Mar 31;61(4):559-62. doi: 10.1084/jem.61.4.559.
4
Additive effects of certain transforming agents from some variants of pneumococcus.
J Exp Med. 1949 Apr 1;89(4):399-424. doi: 10.1084/jem.89.4.399.
Zotero 插件